Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer.
Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Res Sq. 2023 Mar 22.
View in:
PubMed
authors with profiles
Marilyn L. Kwan, PhD
Mai Nhu Nguyen-Huynh, MD, MAS
Carlos Iribarren, MD, MPH, PhD
Romain S. Neugebauer, PhD
Lawrence H. Kushi, ScD